IL6 and neoplasm: CXCL7 from MSCs interacts with cancer cells via the IL-8 receptor, also known as C-X-C chemokine receptor type 2 (CXCR2), causing tumors to further synthesize IL-6 and IL-8 (another cytokine involved in tumor-tropism).